Cetuximab as Therapy for Recurrent Non-Small Cell Lung Cancer Patients Who Have Received Prior Therapy

NCT00694603 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
56
Enrollment
OTHER
Sponsor class

Stopped Slow accrual

Conditions

Interventions

Sponsor

Lecia V. Sequist

Collaborators